mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.005 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.006 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.006 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.007 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.007 |